News

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...
Vanda claims that two generics to its sleep disorder drug Hetlioz were approved despite inadequate data and is requesting ...
The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...
There’s still much more to come from the White House on tariffs, but the European Union has now reached a trade agreement ...
Krystal Biotech's decision follows the FDA’s rejection last month of Replimune’s RP1, which works similarly to Krystal ...
While it’s impossible to make apples-to-apples comparisons of the many obesity candidates with so many differences across ...
Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...
In an open letter, Health and Human Services employees asked the Secretary to stop and disavow the spread of health ...
In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo.
The delays, first revealed in Regeneron’s Q2 report, were chalked up to manufacturing issues at Novo Nordisk-owned plants.
Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal ...
Washington has had notable life sciences job growth over the past 10 years, according to a Life Science Washington report.